½ÃÀ庸°í¼­
»óǰÄÚµå
1589754

¼¼°èÀÇ ±â°ü³» Æ©ºê ½ÃÀå : Á¦Ç° À¯Çü, ·çÆ® À¯Çü, ¿ëµµ, ÃÖÁ¾ »ç¿ëÀÚº° ¿¹Ãø(2025-2030³â)

Endotracheal Tubes Market by Product Type (Double Lumen Endotracheal Tube, Preformed Endotracheal Tube, Regular Endotracheal Tube), Route Type (Nasotracheal, Orotracheal), Application, End-User - Global Forecast 2025-2030

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: 360iResearch | ÆäÀÌÁö Á¤º¸: ¿µ¹® 197 Pages | ¹è¼Û¾È³» : 1-2ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡á º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼ÛÀÏÁ¤Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

±â°ü³» Æ©ºê ½ÃÀåÀº 2023³â¿¡ 20¾ï 2,000¸¸ ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â¿¡´Â 21¾ï 8,000¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, CAGR 7.97%·Î ¼ºÀåÇØ 2030³â¿¡´Â 34¾ï 6,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

±â°ü³» Æ©ºê´Â ¼ö¼ú, ¿Ü»ó Ä¡·á, ½É°¢ÇÑ Áúº´ µî¿¡¼­ Àΰø È£ÈíÀÌ ÇÊ¿äÇÑ È¯ÀÚÀDZ⵵¸¦ È®º¸ÇÏ´Â µ¥ »ç¿ëµÇ´Â Áß¿äÇÑ ÀåÄ¡ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ Æ©ºêÀÇ Çʿ伺Àº ȯÀÚÀÇ ¾ÈÀü¼º°ú È¿°úÀûÀΠȯ±â¸¦ º¸ÀåÇϰí±âµµ Æó»ö°ú »ïŰ´Â °Í°ú °°Àº ÇÕº´ÁõÀÇ À§ÇèÀ» ÁÙÀÌ´Â Áß¿äÇÑ ¿ªÇÒ¿¡ ÀÖ½À´Ï´Ù. ÁÖ·Î ¼ö¼ú½Ç, ÁýÁß Ä¡·á½Ç, ÀÀ±Þ½Ç¿¡¼­ »ç¿ëµÇ¸ç º´¿ø, ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC), ÀçÅÃÄ¡·á µî ÃÖÁ¾ »ç¿ëÀÚ¸¦ À§ÇØ Á¦°øµË´Ï´Ù. ±â°ü³» Æ©ºê ½ÃÀåÀº Àα¸ÀÇ °í·ÉÈ­, ¸¸¼º È£Èí±â ÁúȯÀÇ À¯Çà, ¼¼°è ¼ö¼ú Áõ°¡ÀÇ ¿µÇâÀ» ¹Þ°í ÀÖ½À´Ï´Ù. Ç×±Õ ÄÚÆÃ Æ©ºê ¹× Ä«¸Þ¶ó ½Ã½ºÅÛ ÅëÇÕ Æ©ºê¿Í °°Àº ÃÖ±ÙÀÇ ¹ßÀüÀº ½ÃÀå È®´ëÀÇ Ãֽбâȸ¸¦ µ¸º¸À̰ÔÇÕ´Ï´Ù. ¼¼°èÀûÀ¸·Î °Ç°­ °ü¸® ½Ã½ºÅÛÀÇ ¾÷±×·¹À̵å¿Í ´É·Â È®´ë°¡ °è¼ÓµÇ°í Àֱ⠶§¹®¿¡ ±â¾÷ÀÌ Áö¿ª ƯÀ¯ÀÇ È®´ë³ª Áö¿ªÀÇ °Ç°­ °ü¸® ¿ä±¸¿¡ ´ëÀÀÇÏ´Â Çõ½ÅÀûÀÎ Á¦Ç° Á¦°ø¿¡ ÅõÀÚÇÒ Å« ±âȸ°¡ ÀÖ½À´Ï´Ù. ±×·¯³ª °í±Þ Æ©ºêÀÇ ³ôÀº ºñ¿ë, Àΰø È£Èí±â °ü·Ã Æó·Å À§Çè, ¾ö°ÝÇÑ ±ÔÁ¦ ¿ä±¸ »çÇ×°ú °°Àº °úÁ¦´Â ½ÃÀå ¼ºÀåÀ» ¹æÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº Àڱذú °¨¿° À§ÇèÀ» ÃÖ¼ÒÈ­ÇÏ´Â »ýüÀûÇÕ¼º ¹°Áú ¿¬±¸¿Í ´õ ³ªÀº ȯÀÚ °á°ú¸¦ ÃËÁøÇϱâ À§ÇÑ ½Ç½Ã°£ µ¥ÀÌÅÍ ¸ð´ÏÅ͸µ ±â´ÉÀ» °®Ãá ½º¸¶Æ® Æ©ºê °³¹ß µî ±â¼ú Çõ½Å¿¡ ÁÖ·ÂÇØ¾ß ÇÕ´Ï´Ù. °Ô´Ù°¡ ÇコÄɾîÀÇ ÀÎÇÁ¶ó Á¤ºñ°¡ ÁøÇàµÇ´Â ½ÅÈï±¹ ½ÃÀå¿¡¼­ÀÇ À¯Åë¸ÁÀÇ È®´ëµµ Å« ±âȸ°¡ µË´Ï´Ù. ½ÃÀåÀº ¿ªµ¿ÀûÀÌ°í °æÀïÀÌ ½ÉÇÏ°í ±â¼úÀû Áøº¸¿Í Àü·«Àû ÆÄÆ®³Ê½Ê¿¡ ÁßÁ¡À» µÎ°í ÀÖ´Â °ÍÀÌ Æ¯Â¡ÀÔ´Ï´Ù. ÀÌ ½ÃÀå¿¡¼­ ¼º°øÇϱâ À§Çؼ­´Â ȯÀÚ Àα¸ Åë°è, º´¿ø ÀÎÇÁ¶ó ´É·Â ¹× ±ÔÁ¦ ÇÁ·¹ÀÓ ¿öÅ©¸¦ ÀÌÇØÇÏ´Â °ÍÀÌ Áß¿äÇÕ´Ï´Ù. Áö¼ÓÀûÀÎ R&D ¹× °Ç°­ °ü¸® Á¦°ø¾÷ü¿ÍÀÇ Àü·«Àû Á¦ÈÞ´Â ÁøÈ­ÇÏ´Â ±â°ü³» Æ©ºê ÀÀ¿ëÀÇ »óȲ¿¡¼­ ¼ºÀå°ú °æÀï ¿ìÀ§¸¦ ÃËÁøÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÁÖ¿ä ½ÃÀå Åë°è
±âÁسâ(2023) 20¾ï 2,000¸¸ ´Þ·¯
¿¹Ãø³â(2024) 21¾ï 8,000¸¸ ´Þ·¯
¿¹Ãø³â(2030) 34¾ï 6,000¸¸ ´Þ·¯
CAGR(%) 7.97%

½ÃÀå ¿ªÇÐ: ºü¸£°Ô ÁøÈ­ÇÏ´Â ±â°ü³» Æ©ºê ½ÃÀåÀÇ ÁÖ¿ä ½ÃÀå ÀλçÀÌÆ® °ø°³

±â°ü³» Æ©ºê ½ÃÀåÀº ¼ö¿ä ¹× °ø±ÞÀÇ ¿ªµ¿ÀûÀÎ »óÈ£ÀÛ¿ë¿¡ ÀÇÇØ º¯¸ð¸¦ ÀÌ·ç°í ÀÖ½À´Ï´Ù. »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ ¾ò´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ µ¿ÇâÀ» Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÔÀ¸·Î½á ±â¾÷Àº Á¤Ä¡Àû, Áö¸®Àû, ±â¼úÀû, »çȸÀû, °æÁ¦ÀûÀÎ ¿µ¿ª¿¡ °ÉÄ£ ´Ù¾çÇÑ ¸®½ºÅ©¸¦ °æ°¨ÇÒ ¼ö ÀÖÀ½°ú µ¿½Ã¿¡ ¼ÒºñÀÚ Çൿ°ú ±×°ÍÀÌ Á¦Á¶ ºñ¿ë°ú ±¸¸Å µ¿Çâ¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» º¸´Ù ¸íÈ®ÇÏ°Ô ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ
    • ¸¸¼º Áúȯ¿¡ °É¸®±â ½¬¿î °í·ÉÈ­ Àα¸ Áõ°¡
    • ¿Ü°ú ¼ö¼ú Áõ°¡
    • °¨¿° À§ÇèÀÇ ÀúÇÏ µî, ±â°ü³» Æ©ºê°¡ Á¦°øÇÏ´Â ¸Þ¸®Æ®¿¡ ´ëÇÑ ³ôÀº ¼ö¿ä
  • ½ÃÀå ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ¼ö¼ú ÈÄ ÇÕº´Áõ À§ÇèÀÌ ³ô´Ù
  • ½ÃÀå ±âȸ
    • ±â°ü³» Æ©ºêÀÇ ±â¼úÀû Áøº¸
    • Ç×±Õ ¹× Ç×ÀÀ°í ÄÚÆÃÀ» ½Ç½ÃÇÑ ±â°ü³» Æ©ºêÀÇ °³¹ß Áõ°¡
  • ½ÃÀåÀÇ °úÁ¦
    • ±â°ü³» Æ©ºê¸¦ °ü¸®ÇÏ´Â ¼÷·ÃµÈ Àü¹®°¡ÀÇ ºÎÁ·

Porter's Five Forces: ±â°ü ³» Æ©ºê ½ÃÀåÀ» Ž»öÇÏ´Â Àü·« µµ±¸

Porter's Five Forces ÇÁ·¹ÀÓ ¿öÅ©´Â ½ÃÀå »óȲ°æÀï ±¸µµ¸¦ ÀÌÇØÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. Porter's Five Forces Framework´Â ±â¾÷ÀÇ °æÀï·ÂÀ» Æò°¡Çϰí Àü·«Àû ±âȸ¸¦ ޱ¸ÇÏ´Â ¸íÈ®ÇÑ ±â¼úÀ» Á¦°øÇÕ´Ï´Ù. ÀÌ ÇÁ·¹ÀÓ¿öÅ©´Â ±â¾÷ÀÌ ½ÃÀå ³» ¼¼·Âµµ¸¦ Æò°¡ÇÏ°í ½Å±Ô »ç¾÷ÀÇ ¼öÀͼºÀ» °áÁ¤ÇÏ´Â µ¥ µµ¿òÀÌ µË´Ï´Ù. ÀÌ·¯ÇÑ ÅëÂûÀ» ÅëÇØ ±â¾÷Àº ÀÚ»çÀÇ °­Á¡À» Ȱ¿ëÇϰí, ¾àÁ¡À» ÇØ°áÇϰí, ÀáÀçÀûÀÎ °úÁ¦¸¦ ÇÇÇÒ ¼ö ÀÖÀ¸¸ç, º¸´Ù °­ÀÎÇÑ ½ÃÀå¿¡¼­ÀÇ Æ÷Áö¼Å´×À» º¸ÀåÇÒ ¼ö ÀÖ½À´Ï´Ù.

PESTLE ºÐ¼® : ±â°ü³» Æ©ºê ½ÃÀå¿¡¼­ ¿ÜºÎ·ÎºÎÅÍÀÇ ¿µÇâ ÆÄ¾Ç

¿ÜºÎ °Å½Ã ȯ°æ ¿äÀÎÀº ±â°ü ³» Æ©ºê ½ÃÀåÀÇ ¼º°ú ¿ªÇÐÀ» Çü¼ºÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÑ ¿ªÇÒÀ»ÇÕ´Ï´Ù. Á¤Ä¡Àû, °æÁ¦Àû, »çȸÀû, ±â¼úÀû, ¹ýÀû, ȯ°æÀû ¿äÀÎ ºÐ¼®Àº ÀÌ·¯ÇÑ ¿µÇâÀ» Ž»öÇÏ´Â µ¥ ÇÊ¿äÇÑ Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù. PESTLE ¿äÀÎÀ» Á¶»çÇÔÀ¸·Î½á ±â¾÷Àº ÀáÀçÀûÀÎ À§Çè°ú ±âȸ¸¦ ´õ Àß ÀÌÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ±â¾÷Àº ±ÔÁ¦, ¼ÒºñÀÚ ¼±È£, °æÁ¦ µ¿ÇâÀÇ º¯È­¸¦ ¿¹ÃøÇÏ°í ¾ÕÀ¸·Î ¿¹»óµÇ´Â Àû±ØÀûÀÎ ÀÇ»ç °áÁ¤À» ÇÒ Áغñ¸¦ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå Á¡À¯À² ºÐ¼® : ±â°ü ³» Æ©ºê ½ÃÀå °æÀï ±¸µµ ÆÄ¾Ç

±â°ü³» Æ©ºê ½ÃÀåÀÇ »ó¼¼ÇÑ ½ÃÀå Á¡À¯À² ºÐ¼®À» ÅëÇØ °ø±Þ¾÷üÀÇ ¼º°ú¸¦ Á¾ÇÕÀûÀ¸·Î Æò°¡ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±â¾÷Àº ¼öÀÍ, °í°´ ±â¹Ý, ¼ºÀå·ü µî ÁÖ¿ä ÁöÇ¥¸¦ ºñ±³ÇÏ¿© °æÀï Æ÷Áö¼Å´×À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù. ÀÌ ºÐ¼®À» ÅëÇØ ½ÃÀå ÁýÁß, ´ÜÆíÈ­, ÅëÇÕ µ¿ÇâÀ» ¹àÇô³»°í º¥´õµéÀº °æÀïÀÌ Ä¡¿­ÇØÁö´Â °¡¿îµ¥ ÀÚ»çÀÇ ÁöÀ§¸¦ ³ôÀÌ´Â Àü·«Àû ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ ÇÊ¿äÇÑ Áö½ÄÀ» ¾òÀ» ¼ö ÀÖ½À´Ï´Ù.

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º : ±â°ü ³» Æ©ºê ½ÃÀå¿¡¼­ °ø±Þ¾÷üÀÇ ¼º´É Æò°¡

FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º´Â ±â°ü ³» Æ©ºê ½ÃÀå¿¡¼­ º¥´õ¸¦ Æò°¡ÇÏ´Â Áß¿äÇÑ µµ±¸ÀÔ´Ï´Ù. ¿¡ µû¶ó °áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù. ³× °¡Áö »çºÐ¸éÀ» ÅëÇØ º¥´õ¸¦ ¸íÈ®Çϰí Á¤È®ÇÏ°Ô ºÐÇÒÇϰí Àü·« ¸ñÇ¥¿¡ °¡Àå ÀûÇÕÇÑ ÆÄÆ®³Ê ¹× ¼Ö·ç¼ÇÀ» ÆÄ¾ÇÇÒ ¼ö ÀÖ½À´Ï´Ù.

Àü·« ºÐ¼® ¹× Ãßõ : ±â°ü ³» Æ©ºê ½ÃÀå¿¡¼­ ¼º°ø¿¡ ´ëÇÑ ±æÀ» ±×¸³´Ï´Ù.

±â°ü³» Æ©ºê ½ÃÀåÀÇ Àü·« ºÐ¼®Àº ¼¼°è ½ÃÀå¿¡¼­ÀÇ ÇÁ·¹Á𽺠°­È­¸¦ ¸ñÇ¥·Î ÇÏ´Â ±â¾÷¿¡ ÇʼöÀûÀÎ ¿ä¼ÒÀÔ´Ï´Ù. ÀÌ Á¢±Ù¹ýÀ» ÅëÇØ °æÀï ±¸µµ¿¡¼­ °úÁ¦¸¦ ±Øº¹ÇÏ°í »õ·Î¿î ºñÁî´Ï½º ±âȸ¸¦ Ȱ¿ëÇÏ¿© Àå±âÀûÀÎ ¼º°øÀ» °ÅµÑ ¼ö Àִ üÁ¦¸¦ ±¸ÃàÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­´Â ÁÖ¿ä °ü½É ºÐ¾ß¸¦ Æ÷°ýÇÏ´Â ½ÃÀåÀÇ Á¾ÇÕÀûÀÎ ºÐ¼®À» Á¦°øÇÕ´Ï´Ù.

1. ½ÃÀå ħÅõ: ÇöÀç ½ÃÀå ȯ°æÀÇ »ó¼¼ÇÑ °ËÅä, ÁÖ¿ä ±â¾÷ÀÇ ±¤¹üÀ§ÇÑ µ¥ÀÌÅÍ, ½ÃÀå µµ´Þ¹üÀ§ ¹× Àü¹ÝÀûÀÎ ¿µÇâ·Â Æò°¡.

2. ½ÃÀå °³Ã´µµ: ½ÅÈï ½ÃÀåÀÇ ¼ºÀå ±âȸ¸¦ ÆÄ¾ÇÇÏ°í ±âÁ¸ ºÐ¾ßÀÇ È®Àå °¡´É¼ºÀ» Æò°¡ÇÏ¸ç ¹Ì·¡ ¼ºÀåÀ» À§ÇÑ Àü·«Àû ·Îµå¸ÊÀ» Á¦°øÇÕ´Ï´Ù.

3. ½ÃÀå ´Ù¾çÈ­: ÃÖ±Ù Á¦Ç° Ãâ½Ã, ¹Ì°³Ã´ Áö¿ª, ¾÷°èÀÇ ÁÖ¿ä Áøº¸, ½ÃÀåÀ» Çü¼ºÇÏ´Â Àü·«Àû ÅõÀÚ¸¦ ºÐ¼®ÇÕ´Ï´Ù.

4. °æÀï Æò°¡ ¹× Á¤º¸ : °æÀï ±¸µµ¸¦ öÀúÈ÷ ºÐ¼®ÇÏ¿© ½ÃÀå Á¡À¯À², »ç¾÷ Àü·«, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÀÎÁõ, ±ÔÁ¦ ´ç±¹ ½ÂÀÎ, ƯÇã µ¿Çâ, ÁÖ¿ä ±â¾÷ÀÇ ±â¼ú Áøº¸ µîÀ» °ËÁõÇÕ´Ï´Ù.

5. Á¦Ç° °³¹ß ¹× Çõ½Å : ¹Ì·¡ ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÃÖ÷´Ü ±â¼ú, R&D Ȱµ¿, Á¦Ç° Çõ½ÅÀ» °­Á¶ÇÕ´Ï´Ù.

¶ÇÇÑ ÀÌÇØ°ü°èÀÚ°¡ ÃæºÐÇÑ Á¤º¸¸¦ ¹ÙÅÁÀ¸·Î ÀÇ»ç °áÁ¤À» ³»¸®´Â µ¥ µµ¿òÀÌ µÇ´Â Áß¿äÇÑ Áú¹®¿¡ ÀÀ´äÇÕ´Ï´Ù.

1. ÇöÀç ½ÃÀå ±Ô¸ð¿Í ÇâÈÄ ¼ºÀå ¿¹ÃøÀº?

2. ÃÖ°íÀÇ ÅõÀÚ ±âȸ¸¦ Á¦°øÇÏ´Â Á¦Ç°, ºÎ¹® ¹× Áö¿ªÀº ¾îµðÀԴϱî?

3. ½ÃÀåÀ» Çü¼ºÇÏ´Â ÁÖ¿ä ±â¼ú µ¿Çâ°ú ±ÔÁ¦ÀÇ ¿µÇâÀº?

4. ÁÖ¿ä º¥´õÀÇ ½ÃÀå Á¡À¯À²°ú °æÀï Æ÷Áö¼ÇÀº?

5. º¥´õ ½ÃÀå ÁøÀÔ¡¤Ã¶¼ö Àü·«ÀÇ ¿øµ¿·ÂÀÌ µÇ´Â ¼öÀÍ¿ø°ú Àü·«Àû ±âȸ´Â ¹«¾ùÀΰ¡?

¸ñÂ÷

Á¦1Àå ¼­¹®

Á¦2Àå Á¶»ç ¹æ¹ý

Á¦3Àå ÁÖ¿ä ¿ä¾à

Á¦4Àå ½ÃÀå °³¿ä

Á¦5Àå ½ÃÀå ÀλçÀÌÆ®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
      • ¸¸¼º Áúȯ¿¡ °É¸®±â ½¬¿î °í·ÉÈ­ Àα¸ Áõ°¡
      • ¿Ü°ú ¼ö¼úÀÇ °Ç¼ö Áõ°¡
      • °¨¿° À§ÇèÀÇ ÀúÇÏ µî, ±â°ü³» Æ©ºê°¡ Á¦°øÇÏ´Â ¸Þ¸®Æ®¿¡ ´ëÇÑ ¼ö¿ä°¡ ³ô´Ù
    • ¾ïÁ¦¿äÀÎ
      • ¼ö¼ú ÈÄ ÇÕº´ÁõÀÇ À§ÇèÀÌ ³ô´Ù
    • ±âȸ
      • ±â°ü³» Æ©ºê¿¡ À־ÀÇ ±â¼úÀû Áøº¸
      • Ç×±Õ¼º ¹× Ç×ÀÀ°í¼º ÄÚÆÃ Æ¯¼ºÀ» °®Ãá ±â°ü³» Æ©ºêÀÇ °³¹ß Áõ°¡
    • °úÁ¦
      • ±â°ü³» Æ©ºê¸¦ °ü¸®ÇÒ ¼ö ÀÖ´Â ¼÷·ÃµÈ Àü¹®°¡ÀÇ ºÎÁ·
  • ½ÃÀå ¼¼ºÐÈ­ ºÐ¼®
  • Porter's Five Forces ºÐ¼®
  • PESTEL ºÐ¼®
    • Á¤Ä¡Àû
    • °æÁ¦
    • »ç±³
    • ±â¼úÀû
    • ¹ý·ü»ó
    • ȯ°æ

Á¦6Àå ±â°ü³» Æ©ºê ½ÃÀå : Á¦Ç° À¯Çüº°

  • ÀÌÁß³»°­ ±â°ü³» Æ©ºê
  • ¼ºÇüµÈ ±â°ü³» Æ©ºê
  • ÀÏ¹Ý ±â°ü³» Æ©ºê
  • °­È­ ±â°ü³» Æ©ºê

Á¦7Àå ±â°ü³» Æ©ºê ½ÃÀå : ·çÆ® À¯Çüº°

  • °æºñ ±â°ü
  • °æ±¸ ±â°ü

Á¦8Àå ±â°ü³» Æ©ºê ½ÃÀå : ¿ëµµº°

  • ±ä±Þ Ä¡·á
  • Ä¡·á

Á¦9Àå ±â°ü³» Æ©ºê ½ÃÀå : ÃÖÁ¾ »ç¿ëÀÚº°

  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • Ŭ¸®´Ð
  • º´¿ø

Á¦10Àå ¾Æ¸Þ¸®Ä«ÀÇ ±â°ü³» Æ©ºê ½ÃÀå

  • ¾Æ¸£ÇîÆ¼³ª
  • ºê¶óÁú
  • ij³ª´Ù
  • ¸ß½ÃÄÚ
  • ¹Ì±¹

Á¦11Àå ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ±â°ü³» Æ©ºê ½ÃÀå

  • È£ÁÖ
  • Áß±¹
  • Àεµ
  • Àεµ³×½Ã¾Æ
  • ÀϺ»
  • ¸»·¹À̽þÆ
  • Çʸ®ÇÉ
  • ½Ì°¡Æ÷¸£
  • Çѱ¹
  • ´ë¸¸
  • ű¹
  • º£Æ®³²

Á¦12Àå À¯·´¡¤Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ±â°ü³» Æ©ºê ½ÃÀå

  • µ§¸¶Å©
  • ÀÌÁýÆ®
  • Çɶõµå
  • ÇÁ¶û½º
  • µ¶ÀÏ
  • À̽º¶ó¿¤
  • ÀÌÅ»¸®¾Æ
  • ³×´ú¶õµå
  • ³ªÀÌÁö¸®¾Æ
  • ³ë¸£¿þÀÌ
  • Æú¶õµå
  • īŸ¸£
  • ·¯½Ã¾Æ
  • »ç¿ìµð¾Æ¶óºñ¾Æ
  • ³²¾ÆÇÁ¸®Ä«
  • ½ºÆäÀÎ
  • ½º¿þµ§
  • ½ºÀ§½º
  • ÅÍŰ
  • ¾Æ¶ø¿¡¹Ì¸®Æ®(UAE)
  • ¿µ±¹

Á¦13Àå °æÀï ±¸µµ

  • ½ÃÀå Á¡À¯À² ºÐ¼® 2023
  • FPNV Æ÷Áö¼Å´× ¸ÅÆ®¸¯½º, 2023
  • °æÀï ½Ã³ª¸®¿À ºÐ¼®
  • Àü·« ºÐ¼®°ú Á¦¾È

±â¾÷ ¸ñ·Ï

  • Airway Innovations, LLC
  • Armstrong Medical Ltd
  • Bactiguard Holding AB
  • CR Bard, Inc.
  • Convatec Group PLC
  • ENOX Biopharma Inc.
  • Fuji Systems Corporation
  • Hollister Co.
  • Hospiteknik Healthcare
  • Koken Co., Ltd.
  • Medline Industries Inc.
  • Medtronic PLC
  • N8 Medical LLC
  • Neurovision Medical Products, Inc.
  • NuVasive, Inc.
  • Parker Medical Inc.
  • Royax Medical solution
  • Sharklet Technologies LLC
  • Smiths Group Plc
  • Sonoma Pharmaceutical
  • Teleflex Incorporated
  • Venner Medical International
JHS 24.11.21

The Endotracheal Tubes Market was valued at USD 2.02 billion in 2023, expected to reach USD 2.18 billion in 2024, and is projected to grow at a CAGR of 7.97%, to USD 3.46 billion by 2030.

Endotracheal tubes are critical devices used to secure airways in patients needing ventilation during surgeries, trauma care, or critical illnesses. The necessity of these tubes lies in their crucial role in ensuring patient safety and effective ventilation, thus reducing the risk of complications such as airway obstruction or aspiration. They are primarily applied in operating rooms, intensive care units, and emergency departments, and serve end-users such as hospitals, ambulatory surgical centers, and home care settings. The market for endotracheal tubes is influenced by aging populations, the prevalence of chronic respiratory diseases, and the rise in surgical procedures worldwide. Recent advancements such as antimicrobial-coated tubes and tubes with integrated camera systems highlight the latest opportunities for market expansion. As healthcare systems globally continue to upgrade and expand their capacities, there is a substantial opportunity for companies to invest in region-specific expansions and innovative product offerings that address local healthcare needs. However, challenges such as the high cost of advanced tubes, risk of ventilator-associated pneumonia, and stringent regulatory requirements could hinder market growth. Companies need to focus on innovation by researching biocompatible materials that minimize irritation and infection risks, and developing smart tubes with real-time data monitoring capabilities to facilitate better patient outcomes. Additionally, expanding distribution networks in emerging markets, where healthcare infrastructure continues to develop, presents a significant opportunity. The market is dynamic and competitive, characterized by a focus on technological advancements and strategic partnerships. Understanding patient demographics, hospital infrastructure capacities, and regulatory frameworks will be key for businesses to navigate and succeed in this market. Continuous research and development, along with strategic collaborations with healthcare providers, can foster growth and competitive advantage in the evolving landscape of endotracheal tube applications.

KEY MARKET STATISTICS
Base Year [2023] USD 2.02 billion
Estimated Year [2024] USD 2.18 billion
Forecast Year [2030] USD 3.46 billion
CAGR (%) 7.97%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Endotracheal Tubes Market

The Endotracheal Tubes Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increase in aging population highly prone to chronic diseases
    • Rising incidences of surgical procedures
    • High demand over the benefits offered by endotracheal tubes such as lowered infections risk
  • Market Restraints
    • High risk of post-surgical complications
  • Market Opportunities
    • Technological advancements in endotracheal tubes
    • Increasing development of endotracheal tubes with antibacterial and anti-coagulant coating qualities
  • Market Challenges
    • Lack of skilled professionals to manage endotracheal tubes

Porter's Five Forces: A Strategic Tool for Navigating the Endotracheal Tubes Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Endotracheal Tubes Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Endotracheal Tubes Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Endotracheal Tubes Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Endotracheal Tubes Market

A detailed market share analysis in the Endotracheal Tubes Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Endotracheal Tubes Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Endotracheal Tubes Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Endotracheal Tubes Market

A strategic analysis of the Endotracheal Tubes Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Endotracheal Tubes Market, highlighting leading vendors and their innovative profiles. These include Airway Innovations, LLC, Armstrong Medical Ltd, Bactiguard Holding AB, C. R. Bard, Inc., Convatec Group PLC, ENOX Biopharma Inc., Fuji Systems Corporation, Hollister Co., Hospiteknik Healthcare, Koken Co., Ltd., Medline Industries Inc., Medtronic PLC, N8 Medical LLC, Neurovision Medical Products, Inc., NuVasive, Inc., Parker Medical Inc., Royax Medical solution, Sharklet Technologies LLC, Smiths Group Plc, Sonoma Pharmaceutical, Teleflex Incorporated, and Venner Medical International.

Market Segmentation & Coverage

This research report categorizes the Endotracheal Tubes Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product Type, market is studied across Double Lumen Endotracheal Tube, Preformed Endotracheal Tube, Regular Endotracheal Tube, and Reinforced Endotracheal Tube.
  • Based on Route Type, market is studied across Nasotracheal and Orotracheal.
  • Based on Application, market is studied across Emergency Treatment and Therapy.
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Clinics, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in aging population highly prone to chronic diseases
      • 5.1.1.2. Rising incidences of surgical procedures
      • 5.1.1.3. High demand over the benefits offered by endotracheal tubes such as lowered infections risk
    • 5.1.2. Restraints
      • 5.1.2.1. High risk of post-surgical complications
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in endotracheal tubes
      • 5.1.3.2. Increasing development of endotracheal tubes with antibacterial and anti-coagulant coating qualities
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of skilled professionals to manage endotracheal tubes
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Endotracheal Tubes Market, by Product Type

  • 6.1. Introduction
  • 6.2. Double Lumen Endotracheal Tube
  • 6.3. Preformed Endotracheal Tube
  • 6.4. Regular Endotracheal Tube
  • 6.5. Reinforced Endotracheal Tube

7. Endotracheal Tubes Market, by Route Type

  • 7.1. Introduction
  • 7.2. Nasotracheal
  • 7.3. Orotracheal

8. Endotracheal Tubes Market, by Application

  • 8.1. Introduction
  • 8.2. Emergency Treatment
  • 8.3. Therapy

9. Endotracheal Tubes Market, by End-User

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Clinics
  • 9.4. Hospitals

10. Americas Endotracheal Tubes Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Endotracheal Tubes Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Endotracheal Tubes Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Airway Innovations, LLC
  • 2. Armstrong Medical Ltd
  • 3. Bactiguard Holding AB
  • 4. C. R. Bard, Inc.
  • 5. Convatec Group PLC
  • 6. ENOX Biopharma Inc.
  • 7. Fuji Systems Corporation
  • 8. Hollister Co.
  • 9. Hospiteknik Healthcare
  • 10. Koken Co., Ltd.
  • 11. Medline Industries Inc.
  • 12. Medtronic PLC
  • 13. N8 Medical LLC
  • 14. Neurovision Medical Products, Inc.
  • 15. NuVasive, Inc.
  • 16. Parker Medical Inc.
  • 17. Royax Medical solution
  • 18. Sharklet Technologies LLC
  • 19. Smiths Group Plc
  • 20. Sonoma Pharmaceutical
  • 21. Teleflex Incorporated
  • 22. Venner Medical International
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦